-
·
Avec l’IA générative, Merck et McKinsey transforment la rédaction clinique
Reimagining R&D with AI Bringing a new drug to market is one of the most high-stakes processes in business and science, requiring an average of ten years and more than a billion dollars. Meanwhile, the number of medicines in the R&D pipeline has doubled over the past decade, intensifying the pressure to innovate. The biopharma…